KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to $36.9 million.

  • Charles River Laboratories International's Long-Term Deferred Tax fell 278.17% to $36.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.9 million, marking a year-over-year decrease of 278.17%. This contributed to the annual value of $42.2 million for FY2024, which is 471.71% up from last year.
  • Per Charles River Laboratories International's latest filing, its Long-Term Deferred Tax stood at $36.9 million for Q3 2025, which was down 278.17% from $46.9 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Long-Term Deferred Tax ranged from a high of $48.8 million in Q1 2025 and a low of $31.9 million during Q2 2021
  • In the last 5 years, Charles River Laboratories International's Long-Term Deferred Tax had a median value of $40.2 million in 2021 and averaged $39.8 million.
  • Per our database at Business Quant, Charles River Laboratories International's Long-Term Deferred Tax plummeted by 2548.24% in 2021 and then skyrocketed by 3328.0% in 2022.
  • Charles River Laboratories International's Long-Term Deferred Tax (Quarter) stood at $40.2 million in 2021, then increased by 2.58% to $41.3 million in 2022, then dropped by 2.38% to $40.3 million in 2023, then rose by 4.72% to $42.2 million in 2024, then dropped by 12.5% to $36.9 million in 2025.
  • Its last three reported values are $36.9 million in Q3 2025, $46.9 million for Q2 2025, and $48.8 million during Q1 2025.